NatWest Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
2024
Q1
$2.8M Sell
2023
Q4
$2.81M Buy
2023
Q3
$2.03M Buy
2023
Q2
$2.01M Buy
2023
Q1
$1.79M Sell
2022
Q4
$5.58M Buy
2022
Q3
$5.48M Buy
2015
Q4
Sell
2015
Q3
$735K Buy
2015
Q2
Sell
2015
Q1
$904K Buy
2014
Q4
$321 Buy
2014
Q2
Sell
2014
Q1
$1.07M Sell
2013
Q4
$2.5M Buy
2013
Q3
$2.13M Buy
2013
Q2
$2.23M Buy